Latest news
State Street Corporation (NYSE: STT) discloses 5.3% holding in Myriad Genetics - Stock TitanStock Titan · Fri, 07 Aug 2026 14:10:28 GMTOpus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:20:07 GMTOpus Genetics Reports Q2 2026 Results and Advances Multiple IRD Gene Therapy Programs with OPGx-BEST1 Data Expected in September - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTOpus Genetics reports Q2 2026 results: $0.8M revenue, $8.1M net loss, $88.8M cash - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMT4DMT reports new phase 2b gene therapy data for wet AMD - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Wed, 05 Aug 2026 18:49:23 GMTSOPHiA GENETICS Reports Second Quarter 2026 Results - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 10:45:00 GMT[10-Q] MYRIAD GENETICS INC Quarterly Earnings Report - Stock TitanStock Titan · Fri, 31 Jul 2026 12:02:12 GMTFulgent Genetics, Inc. Reports Unaudited Impairment of Intangible Assets for the Second Quarter Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 30 Jul 2026 20:05:00 GMT